De Braud Filippo Guglielmo Maria
Full professor
SSD
MED/06 - MEDICAL ONCOLOGY
Competition sector
06/D3 - BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY
Specialisation School Director
Contacts
Additional phone numbers
University email address
Education
A.Y. 2019/2020
A.Y. 2018/2019
A.Y. 2017/2018
Research
Publications
-
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study / G. Fucà, L. Mariani, S. Lo Vullo, G. Galli, R. Berardi, M. Di Nicola, C. Vernieri, D. Morelli, K. Dotti, I. Fiordoliva, S. Rinaldi, C. Gavazzi, F. Pietrantonio, M. Platania, F. de Braud. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 9:1(2019 Dec 01).
-
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms / M. Milione, R. Miceli, F. Barretta, A. Pellegrinelli, P. Spaggiari, G. Tagliabue, G. Centonze, C. Paolino, A. Mangogna, K. Kankava, S. Pusceddu, L. Giacomelli, A. Corti, C. Cotsoglou, V. Mazzaferro, G. Sozzi, F. de Braud, G. Pruneri, A. Anichini. - In: THE JOURNAL OF PATHOLOGY. CLINICAL RESEARCH. - ISSN 2056-4538. - 5:4(2019 Oct), pp. 217-226.
-
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? / F. Nichetti, F.S. Falvella, R. Miceli, S. Cheli, R. Gaetano, G. Fucà, G. Infante, A. Martinetti, C. Antoniotti, A. Falcone, M. Di Bartolomeo, C. Cremolini, F. de Braud, F. Pietrantonio. - In: PHARMACOGENOMICS JOURNAL. - ISSN 1470-269X. - 19:5(2019 Oct), pp. 465-472.
-
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer / G. Galli, A. De Toma, F. Pagani, G. Randon, B. Trevisan, A. Prelaj, R. Ferrara, C. Proto, D. Signorelli, M. Ganzinelli, N. Zilembo, F. de Braud, M. Garassino, G. Lo Russo. - In: LUNG CANCER. - ISSN 0169-5002. - 137(2019 Sep 10), pp. 38-42.
-
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial / F. Pietrantonio, F. Morano, S. Corallo, R. Miceli, S. Lonardi, A. Raimondi, C. Cremolini, L. Rimassa, F. Bergamo, A. Sartore-Bianchi, M. Tampellini, P. Racca, M. Clavarezza, R. Berenato, M. Caporale, M. Antista, M. Niger, V. Smiroldo, R. Murialdo, A. Zaniboni, V. Adamo, G. Tomasello, M. Giordano, F. Petrelli, R. Longarini, S. Cinieri, A. Falcone, V. Zagonel, M. Di Bartolomeo, F. de Braud. - In: JAMA ONCOLOGY. - ISSN 2374-2437. - 5:9(2019 Sep), pp. 1268-1275.